RBC Capital starts Advanced Medical Solutions at ‘sector perform’.
RBC Capital Markets initiated coverage of Advanced Medical Solutions on Thursday with a ‘sector perform’ rating and 285p price target, as it sees a clear path to a re-rating but remains on the sidelines until then.
Advanced Medical Solutions Group
26 April 2024 17:19:21
Source: Sharecast
It said AMS is a well-run, cash generative business that is set to bolster its already-impressive positioning in defensive end markets with a range of recent and upcoming launches.
"However, the current share price is already full, in our view, and our £2.85/share price target has insufficient implied upside for us to recommend buying the shares at this stage," it said.
RBC said its sees "meaningful" upside potential from surgical sealant Seal-G, and may revisit its rating on positive clinical and commercial developments.
AMS develops and manufactures tissue-healing technology.
N/A
ISIN:
N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes
Compare our accounts
Whether you're looking for a Share Dealing Account, Stocks and Shares ISA or a Self-Invested Personal Pension (SIPP), we've got an account to suit your needs..
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
